Feedback Share Discussion Threads

[ducatiman] 19/1/2020 10:36

All very promising Ged. Let’s hope we get a breakthrough soon.

[ged5] 19/1/2020 10:22

Similar thoughts, Ducatiman!

Some interesting ideas here:

The second NHS Clinical Entrepreneur to speak was Dr Tom Oakley, a radiologist by background who is now the CEO of a public limited company that has floated on the London Stock Exchange. He has raised £2 million and employed 12 people to help him develop his product.

He explained that, as a radiologist, his biggest problem with the healthcare system had been that it was not possible to share medical images easily and that communication between clinical colleagues in different locations was difficult. “If you’re having a stroke, even in the centre of London, and you have to go down the road to another hospital for a thrombectomy, it can take up to three hours for us to exchange your images from the hospital you were at to the hospital you’re going to,” he said.

In response, he had created Bleepa, a picture archiving and communication system (PACS) that operated on a mobile phone. “You can access any medical image – MRI, CT, plain film studies, even fluoro – from wherever you are in the world,” he said.

The system also allows clinicians to communicate through instant messaging. This means that a clinician can highlight a feature of interest on a scan, for example, and ask colleagues about it.

His company is now exploring whether patients might be interested in accessing the system, which would allow them to keep copies of their scans. “Quite useful if you’re overseas and suddenly you’re taken ill and your CTs from the UK can be seen by clinicians in the States,” he suggested.

Other potential developments include incorporating AI imaging tools into the platform to help non-specialists interpret an image while waiting for a specialist opinion.

He wondered if there might be potential for the system to be used in the veterinary field, asking if members of the audience would benefit from being able to share images and whether owners might want their pets’ images.

One audience member commented that issues of liability and indemnity might arise if a vet outside the RCVS’s jurisdiction – for example, living overseas – used this type of technology to comment on images from a UK case and a problem arose, and suggested that this was a “live sandbox issue that we should perhaps be thinking about now”. “The tech’s the easy bit, right?” replied Dr Oakley, “It’s all the bits that go around it…”

He reported that his company runs sandboxes for testing and regulating AI and is evaluating some of this work with NICE and the Health Research Authority. “We will build a sandbox of 10,000 CTs and deploy the AI tool into it and we will see what the outcome is compared to radiology reports. So you get some real-world analysis of these types of tools,” he concluded.

[ged5] 19/1/2020 10:17

On reflection that was a very good week for Feedback.

Om Monday out of the blue we had a RNSNON about an agreement with Imaging Engineering LLC, a US-based specialist technology provider, to support the installation and refitting of modernised fluoroscopy equipment across the US.

But it wasn't just about a signed agreement it's new income.

A small number of initial installations have already been performed by Imaging Engineering and the first licence fees have now been received by Feedback Medical.

Nor was it just about fluoroscopy. There is confidence about Bleepa.

For Feedback, the licence fee provides us with a new stream of revenue reflecting our strategic focus on the Cadran product portfolio which includes our flagship product, Bleepa, and its commercial roll-out in 2020.

Then on Wednesday we had the interview where we were given a very promising update on the Bleepa trial.

Balaji Ganeshan left but TexRAD remains.

LR2 has yet again shared his research. He's provided us with papers where TexRAD is being used for research in High Blood Pressure and Texture Analysis could be used for decision making for patients with melanoma.

There's also suggestions about the use of Bleepa in the veterinary profession.

So the newsflow gives indication of a very exciting year. The share price will eventually reflect the work being done.

[ducatiman] 19/1/2020 09:52

Well that was an interesting week! Ganeshan walks, interesting contract in the US. short interview with TO which seems to indicate that the trial is going well, fluoroscopy deal has worldwide potential, not a word about Texrad! The share price continues to languish sub 1p. Next week?

[lr2] 18/1/2020 21:38

Vet Bleepa (last October).

[lr2] 18/1/2020 21:15

Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process–A systematic review

[davydoo] 17/1/2020 13:46

You’re new, but you bailed out out after 6 months, eh?

[demonboy] 17/1/2020 11:55

I bailed out 2 days ago waited 6 months for this to move.

[ged5] 17/1/2020 11:43

You're not at Oldham General Hospital are you? :)

[demonboy] 17/1/2020 11:40

As an investor

[demonboy] 17/1/2020 11:40

I'm also new to feedback plc

[demonboy] 17/1/2020 11:39

Its interesting to see these developments from tech sciences

[demonboy] 17/1/2020 11:38

I work within the nhs.

[ged5] 17/1/2020 11:33

Great to be reminded about all these old snippets of news, Demonboy.

For now Bleepa and Fluoroscopy upgrades are the main events.

Once the money is flowing in, then if TexRAD hasn't been sold (the consensus and some logic seems to be that it won't) then we might get some exciting developments.

You are obviously trying to find out as much as you can about Feedback, so what attracted you to Feedback?

[demonboy] 17/1/2020 07:45

Also in use in some European countries.

[demonboy] 17/1/2020 07:42

https://www.google.com/amp/s/www.proactiveinvestors.co.uk/companies/amp/news/204498

[demonboy] 17/1/2020 07:26

LR2 that should be an interesting event next week.

[lr2] 17/1/2020 02:00

Artificial Intelligence in Radiology 2020

23-24 JANUARY 2020
Day 1 at 11:40

TexRAD Texture (Radiomics) analysis of CT and MR data – ready for routine clinical use?

Mr Balaji Ganeshan, Senior Imaging Scientist, Institute of Nuclear Medicine,
University College London; Founder of TexRAD Texture (Radiomics) – software

[demonboy] 16/1/2020 17:03

Pennine Acute Hospitals NHS Trust was given the green light from NHS England in February for a £10million digital programme to invest in digital technology and improved patient care systems across hospitals in Bury, Oldham, Rochdale and North Manchester. The funding is part of its fast follower programme.

[davydoo] 16/1/2020 14:25

He's a director of a subsidiary not the plc so I don't think so

[ged5] 16/1/2020 14:25

Thanks again!

My apologies, Davydoo.